Acarix AB (publ) (ACARIX.ST) Research

Acarix AB (publ) is a medical technology company that develops and introduces diagnostic solutions for cardiovascular conditions to markets including Germany, Sweden, the Middle East, Switzerland, Austria, and globally. Their key product is the CADScor System, an exceptionally sensitive, non-invasive analytical device designed for the detection of coronary artery disease. Founded in 2009, Acarix AB (publ) maintains its headquarters in Malmö, Sweden.

Market snapshot

Symbol
ACARIX.ST
Price
$0.25
Day change
-1.19%
Market cap
$279.7M
P/E ratio
-6.62x
52-week range
0.2245-0.471
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • AlzeCure Pharma AB (publ) (ALZCUR.ST)
  • Boule Diagnostics AB (publ) (BOUL.ST)
  • Clinical Laserthermia Systems AB (publ) (CLS-B.ST)
  • Elicera Therapeutics AB (publ) (ELIC.ST)
  • Integrum AB (publ) (INTEG-B.ST)
  • Intervacc AB (publ) (IVACC.ST)
  • Mentice AB (publ) (MNTC.ST)
  • Nanexa AB (publ) (NANEXA.ST)

Open Acarix AB (publ) (ACARIX.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.